SC 13G
SABBY 13G RNN 12.4.12
- Company
- Opus Genetics, Inc.
- Filed
- December 4, 2012
- Accession Number
- 0001535610-12-000022
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →